Dermal delivery of drugs using different vesicular carriers: A comparative review

Asian Journal of Pharmaceutics

Volumn 6, Issue 4, 2012, Pages 237-244

  Arora, Saahil ^a   Lamba, Harleen ^a   Tiwari, Ravindra ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Dermal delivery; Ethosome; Liposome; Niosome; Transdermal; Transfersome

Indexed keywords

ACICLOVIR; CORTICOSTEROID; DICLOFENAC; DRUG CARRIER; ENOXACIN; ETHOSOME; FINASTERIDE; INSULIN; LEVONORGESTREL; LIDOCAINE; LIPOSOME; METHOTREXATE; MINOXIDIL; NIOSOME; RETINOIC ACID; TESTOSTERONE; TETRACAINE; TRANSFENAC; TRANSFERSOME; TRANSFERSULIN; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; HUMAN; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PSORIASIS; RABBIT; SKIN PENETRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 84875705034     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.107558     Document Type: Article

References (62)

1. Honeywell-Nguyen PL, Bouwstra JA. The in vitro transport of pergolide from surfactant-based elastic vesicles thourough human skin: A suggested mechanism of action. J Control Release 2003;86:145-56.
2. Honeywell-Nguyen PL, Frederik PM, Bomans PH, Junginger HE, Bouwstra JA. Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: Characterization and in vitro transport studies. Pharm Res 2002;19:991-7.
3. Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA. The in vivo transport of elastic vesicles into human skin: Effects of occlusion, volume and duration of application. J Control Release 2003;90:243-55.
4. El Maghouraby GM, Barry BW, Williams AC. Liposomes and skin: From drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-22.
5. Foldvari M, Gesztes A, Mezei M. Dermal drug delivery by liposome encapsulation: Clinical and electron microscopic studies. J Microencapsul 1990;7:479-89.
6. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: Reviewing thouree decades of research. Int J Pharm 2007;332:1-16.
7. Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009;6:813-25.
8. Tortora GJ, Derrickson BH. Principles of Anatomy and Physiology. 12 ed. USA: John Wiley and Sons. 2008. p. 1280.
9. Bangham AD. Surrogate cells or trojan horses. The discovery of liposomes. Bio Essays 1995;17:1081-8.
10. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980;26:1473-7.
11. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration: Gel dosage form. J Pharm Pharmacol 1982;34:473-4.
12. Planas ME, Gonzalez P, Rodriguez L, Sanchez S, Cevc G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth Analg 1992;75:615-21.
13. Fisher R, Murphy M, Hung O, Mezei M, Stewart R. Absorption of liposome-encapsulated tetracaine versus nonliposome-encapsulated tetracaine from open wounds in rabbits. Am J Emerg Med 1994;12:521-3.
14. Foldvari M. In vitro cutaneous and percutaneous delivery and in vivo efficacy of tetracaine from liposomal and conventional vehicles. Pharm Res 1994;11:1593-8.
15. Foldvari M. Effect of vehicle on topical liposomal drug delivery: Petrolatum bases. J Microencapsul 1996;13:589-600.
16. Foldvari M. Non-invasive administration of drugs thourough the skin: Challenges in delivery system design. Pharm Sci Technol Today 2000;3:417-25.
17. Singh R, Vyas SP. Topical liposomal system for localized and controlled drug delivery. J Dermatol Sci 1996;13:107-11.
18. Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Biggio G, et al. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. Eur J Pharm Biopharm 2011;78:27-35.
19. Mura S, Manconi M, Valenti D, Sinico C, Vila AO, Fadda AM. Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target 2011;19:189-96.
20. Fresta M, Puglisi G. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles. J Drug Target 1996;4:95-101.
21. Handjani-Vila RM, Ribier A, Rondot B, Vanlerberghie G. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmet Sci 1979;1:303-14.
22. Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes-non-ionic surfactant vesicles. J Pharm Pharmacol 1985;37:863-8.
23. Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm 2002;234:237-48.
24. Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006;311:11-9.
25. Manconi M, Valenti D, Sinico C, Lai F, Loy G, Fadda AM. Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 2003;260:261-72.
26. Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323:1-10.
27. Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 2009;377:1-8.
28. van Hal DA, Jeremiasse E, Vringer T, Junginger HE, Bouwstra JA. Encapsulation of lidocaine base and hydrochloride into non-ionic surfactant vesicles (NSVs) and diffusion thourough human stratum corneum in vitro. Eur J Pharm Sci 1996;4:147-57.
29. Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: Characterization and in vitro permeation studies. Int J Pharm 2002;231:21-32.
30. Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim Biophys Acta 2001;1514:191-205.
31. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226-32.
32. Cevc G. Drug delivery across the skin. Expert Opin Investig Drugs 1997;6:1887-937.
33. Cevc G. Self-regulating "smart carriers" for non-invasive and targeted drug delivery. Cell Mol Biol Lett 2002;7:224-5.
34. Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1998;1368:201-15.
35. Cevc G, Mazgareanu S, Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int J Pharm 2008;360:29-39.
36. Cevc G, Mazgareanu S, Rother M, Vierl U. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int J Pharm 2008;359:190-7.
37. Cevc G, Gebauer D. Hydration-driven transport of deformable lipid vesicles thourough fine pores and the skin barrier. Biophys J 2003;84:1010-24.
38. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 2003;42:461-74.
39. Cevc G, Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersomes. Biochim Biophys Acta 2003;1614:156-64.
40. Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 2004;1663:61-73.
41. Guo J, Ping Q, Sun G, Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm 2000;194:201-7.
42. Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004;270:119-25.
43. Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241:319-27.
44. Jain S, Sapre R, Tiwary AK, Jain NK. Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization, and performance evaluation. AAPS Pharm Sci Tech 2005;6:E513-22.
45. Jain SK, Gupta Y, Jain A, Rai K. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 2008;15:141-7.
46. Badran M, Shalaby K, Al-Omrani A. Influence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: Dependency on their composition. Sci World J 2012;2012:134876.
47. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J Control Release 2000;65:403-18.
48. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001;22:3053-9.
49. Touitou E. Drug delivery across the skin. Expert Opin Biol Ther 2002;2:723-33.
50. Touitou E, Meidan VM, Horwitz E. Methods for quantitative determination of drug localized in the skin. J Control Release 1998;56:7-21.
51. Kirjavainen M, Mönkkönen J, Saukkosaari M, Valjakka-Koskela R, Kiesvaara J, Urtti A. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release 1999;58:207-14.
52. Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999;7:279-86.
53. Kirjavainen M, Urtti A, Jääskeläinen I, Suhonen TM, Paronen P, Valjakka-Koskela R, et al. Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim Biophys Acta 1996;1304:179-89.
54. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes. Biomaterials 2000;21:1879-85.
55. Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv 2005;12:297-303.
56. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation thourough human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005;106:99-110.
57. López-Pinto JM, González-Rodríguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 2005;298:1-12.
58. Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123:148-54.
59. Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. Liposomes as carriers for dermal delivery of tretinoin: In vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release 2005;103:123-36.
60. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery. Int J Pharm 2006;322:60-6.
61. El Maghouraby GM, Campbell M, Finnin BC. Mechanisms of action of novel skin penetration enhancers: Phospholipid versus skin lipid liposomes. Int J Pharm 2005;305:90-104.
62. Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001;219:61-72.